ESTIMATION OF THE PLASMA CONCENTRATION OF ENDOTHELIN-1 AND SICAM-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES MELLITUS
- Autores: KAPUSTIN R.V1, ARZHANOVA O.N1,2, SOKOLOV D.I1, CHEPANOV S.V1, SELKOV S.A1
-
Afiliações:
- D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
- Saint Petersburg State University
- Edição: Nº 5 (2013)
- Páginas: 36-41
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246925
- ID: 246925
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
R. KAPUSTIN
D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
Email: Kapustin.Roman@gmail.com
Saint Petersburg, Russia
O. ARZHANOVA
D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences; Saint Petersburg State University
Email: arjanova_olga@mail.ru
Department of Obstetrics, Gynecology and Reproductology, Faculty of Medicine Saint Petersburg, Russia
D. SOKOLOV
D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical SciencesSaint Petersburg, Russia
S. CHEPANOV
D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical SciencesSaint Petersburg, Russia
S. SELKOV
D.O. Ott Research Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
Email: selkovsa@mail.ru
Saint Petersburg, Russia
Bibliografia
- George E.M., Granger J.P. Endothelin: key mediator of hypertension in preeclampsia. Am. J. Hypertens. 2011; 24(9): 964-9.
- Lygnos M., Pappa K., Papadaki H., Relakis C., Koumantakis E., Anagnou N. Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo. 2006; 20: 157-63.
- George E., Granger J. Mechanisms and potential therapies for preeclampsia. Curr. Hypertens. Rep. 2011; 13: 269-75.
- Fiore G., Florio P., Micheli L., Nencini C., Rossi M., Cerretani D. et al. Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J. Clin. Endocrinol. Metab. 2005; 90: 4205-10.
- Nezar M., el-Baky A., Soliman O., Abdel-Hady H., Hammad A., Al-Haggar M. Endothelin-1 and leptin as markers of intrauterine growth restriction. Indian J. Pediatr. 2009; 76: 485-8.
- Potenza M., Marasciulo F., Chieppa D., Brigiani G., Formoso G. et al. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am. J. Physiol. 2005; 289: 813-22.
- Montagnani M., Golovchenko I., Kim I., Koh G., Goalstone M., Mundhekar A. et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J. Biol. Chem. 2002; 277: 1794 -9.
- Seligman B., Biolo A., Polanczyk C., Gross J., Clausell N. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care. 2000; 23(9): 1395-400.
- Ang C., Hillier C., Cameron A., Greer A., Lumsden M. The effect of type 1 diabetes mellitus on vascular responses to endothelin-1 in pregnant women. J. Clin. Endocrinol. Metab. 2001; 86: 4939-42.
- Swiderski S., Celewicz Z., Miazgowski T., Ogonowski J. Maternal endothelin-1 and cyclic guanosine monophosphate concentrations in pregnancies complicated by pregravid and gestational diabetes mellitus. Gynecol. Obstet. Invest. 2010; 69: 46-50.
- Telejko B., Zonenberg A., Kuzmicki M., Modzelewska A., Niedziolko-Bagniuk K., Ponurkiewicz A. et al. Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes. Acta Diabetol. 2009; 46: 303-8.
- Krauss T., Emons G., Kuhn W, Augustin H. Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin. Chem. 2002; 48(9): 1418-25.
- Meigs J., Hu B., Rifai N., Manson J. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004. 291:1978-86.
- Loukovaara M., Loukavaara S., Leinonen P., Teramo K., Andersson S. Endothelium-derived nitric oxide metabolites and soluble intercellular adhesion molecule-1 in diabetic and normal pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005; 118(2): 160-5.
- Соколов Д.И., Лесничия М.В., Аминова Э.А., Аржанова О.Н., Сельков С.А. Оценка концентрации sICAM-1 в сыворотке крови беременных и продукции sICAM-1 тканью плаценты. Журнал акушерства и женских болезней. 2009; 58(1): 44-9.
- Петрищев Н.Н., ред. Дисфункция эндотелия. Патогенетическое значение и методы коррекции. СПб.: ИИЦ ВМА; 2007. 296 с.
- Ceriello A., Falleti E., Motz E., Taboga C., Tonutti L., Ezsol Z. et al. Hyperglycemia induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm. Metab. Res. 1998; 30(3): 146-9.
- Bo S., Valpreda S., Menato G., Bardelli C., Botto C., Gambino R. et al. Should we consider gestational diabetes a vascular risk factor? Atherosclerosis. 2007; 194(2): e72-9.
- Kim S., Ryu H, Yang J. Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia. J. Korean Med. Sci. 2004; 19: 688-92.
- Phocas I., Rizos D., Papoulias J., Xyni K., Sarandakou A., Salamalekis E. A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia. J. Perinat. 2000; 20: 114-9.
- Clausen P., Ekbom P., Damm P., Feldt-Rasmussen U., Nielsen B., Mathiesen E., Feldt-Rasmussen B. Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. J. Diabetes Complications. 2007; 21(5): 288-93.
- Chaiworapongsa T., Romero R., Yoshimatsu J., Espinoza J., Kim Y., Park K. et al. Soluble adhesion molecule profile in normal pregnancy and preeclampsia. J. Matern. Fetal Neonatal Med. 1997; 12: 19-27.
- Tziotis J., Malamitsi-Puchner A., Vlachos G., Creatsas G., Michalas S. Adhesion molecules expression in the placental bed ofpregnancies with preeclampsia. Br. J. Obstet. Gynaecol. 2002; 109(2): 197-201.
- Bltiher M., Unger R., Rassoul F., Richter V., Paschke R. Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia. 2002; 45(2): 210-6.
- Konukoglu D., Firtina S., Serin O. The relationship between plasma asymmetric dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance. Metabolism. 2008; 57: 110-5.
- Targher G., Bonadonna R., Alberiche M., Zenere M., Muggeo M., Bonora E. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care. 2001; 24: 1961-6.
- Kautzky-Willer A., Fasching P., Jilma B., Waldhausl W., Wagner O. Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 1997; 82: 4117-21.
- Nan Fang, Yi Ke Da, Xue Xue Bao. Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus. 2007; 27(1): 35-7.